Wiktor Kuliczkowski
Overview
Explore the profile of Wiktor Kuliczkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pietrasik A, Gasecka A, Pawlowski T, Sacha J, Grygier M, Bielawski G, et al.
Kardiol Pol
. 2023 Nov;
81(11):1103-1112.
PMID: 37937354
Background: Impella is a percutaneous mechanical circulatory support device for treatment of cardiogenic shock (CS) and high-risk percutaneous coronary interventions (HR-PCIs). IMPELLA-PL is a national retrospective registry of Impella-treated CS...
22.
Blaziak M, Urban S, Wietrzyk W, Jarocki M, Modrzejewska K, Kuliczkowski W
Postepy Kardiol Interwencyjnej
. 2023 Oct;
19(3):301-302.
PMID: 37854969
No abstract available.
23.
Zalas K, Kuliczkowski W, Pachana J, Mycka R, Rakoczy B
Postepy Kardiol Interwencyjnej
. 2023 Oct;
19(3):298-300.
PMID: 37854966
No abstract available.
24.
Tubek S, Niewinski P, Langner-Hetmanczuk A, Jura M, Kuliczkowski W, Reczuch K, et al.
Front Physiol
. 2023 Aug;
14:1214893.
PMID: 37538377
The most common side effect of ticagrelor is dyspnea, which leads to premature withdrawal of this life-saving medication in 6.5% of patients. Increased chemoreceptors' sensitivity was suggested as a possible...
25.
Kubica J, Adamski P, Gajda R, Gasior M, Gierlotka M, Gil R, et al.
Cardiol J
. 2023 Jul;
30(4):502-505.
PMID: 37401419
No abstract available.
26.
Slawek-Szmyt S, Stepniewski J, Kurzyna M, Kuliczkowski W, Jankiewicz S, Kopec G, et al.
Eur Heart J Acute Cardiovasc Care
. 2023 Jun;
12(9):584-593.
PMID: 37319339
Aims: High- (HR) and intermediate-high risk (IHR) pulmonary embolisms (PEs) are related to high early mortality and long-term sequelae. We aimed to describe clinical outcomes and adverse events in IHR...
27.
Kubler P, Zimoch W, Kosowski M, Protasiewicz M, Kuliczkowski W, Reczuch K
Kardiol Pol
. 2023 Jun;
81(7-8):804-805.
PMID: 37270836
No abstract available.
28.
Kopec G, Araszkiewicz A, Kurzyna M, Slawek-Szmyt S, Stepniewski J, Roik M, et al.
Kardiol Pol
. 2023 Mar;
81(4):423-440.
PMID: 36951599
Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option in the treatment of patients with acute pulmonary embolism at high risk of early...
29.
Zimoch W, Kubler P, Kosowski M, Rakotoarison O, Telichowski A, Kuliczkowski W, et al.
Kardiol Pol
. 2023 Mar;
81(4):398-400.
PMID: 36871297
No abstract available.
30.
Serafin K, Zimoch W, Kuliczkowski W, Reczuch K
Postepy Kardiol Interwencyjnej
. 2023 Feb;
18(3):311-313.
PMID: 36751277
No abstract available.